Background. It has been demonstrated that growth hormone (GH) is synthesized and secreted by human peripheral mononuclear cells (pBMC), and the expression of GH mRNAcan be foundthroughoutthe human immunesystem.
G
ROWTH hormone(GH) is involved in immunomodulation of both cellularand humoral immunity (1) . Of importance to the work performedin this investigation, GH has an effect on B-cell proliferationand also increases IgG and IgE production (2) . Snell-Bagy dwarf mice, which are deficientin GH, have a reduced ability to synthesize antibodies to particular antigens (3), a decreasednumberof splenicT and B cells (4) , and a cellular depletionof the bone marrow (5) .Also, lymphocyte proliferation is blocked by specific antibodies to GH (6) , and an antisenseoligodeoxynucleotide to GH mRNA (7) .
It has been demonstrated that GH is synthesized (6, 8) and secreted (9, 10) by humanperipheralmononuclearcells (PBMCs), and the expression of GH mRNA can be found throughout the human immune system [thymus, tonsil, lymph nodes, and spleen; (8) ]. Furthermore, we have shown that lymphocyteGH mRNA occurs primarilyin B-cell enriched areas in human immune organs (8) .Therefore, we have been interestedin evaluating GH mRNA levels in purifiedB-and T-cell populations from PBMCs. In this study we have used competitive RT-PCR to evaluate whetherhuman Band/or T cells synthesize GH and in whichcell type it predominates.
We chose to study a population of female caregivers of patients with Alzheimer's disease (AD). We have described numerous immune deficits in the chronically stressed AD caregiver population including an inhibition of the ability of NK cells to respond to interferongamma (IFN-'Y) and interleukin 2 [lL-2; (11)], decreased antibody and virus specific T-cell responses to influenza virus vaccination (12) , and decreased expression oflymphocyte GH mRNA (13) . In some caregiversof M212 AD patients,negativechanges occur in both T-and B-cellfunction. Therefore, we were interestedif there was a downregulation of GH gene expression in T and B cells as measured by GH mRNA. Such a finding would support our hypothesis that decreased lymphocyte GH mRNA is involved in the poor immune response to the influenzavirus vaccinethat we have seen in theseindividuals (12) .
MATERIALS AND METHODS
Subjects.-our study population consisted of nine elderly women who sufferedfrom the chronicstress of caring for a relativewithAD, and nine age-and sex-matchedcontrol subjects. The stressinvolvedwith spousalcaregiving has been well characterized (14) . The weights of both groups were coml?arable (controls 71±4 kg vs 73±5 kg for the caregivers). Their ages were similar (controls 68±2 yr vs 64±1.8 for the caregivers). The inclusion criteria for participation in the study included good general health, body mass index <31, and normotensive; no history of a chronic illness; postmenopausal and not on estrogen replacement; and not on any pharmacologic or tobacco products. Participants were asked not to ingest any medication or alcohol24 h precedingthe test day.
T-and B-lymphocytes separation.-Starting with 30 ml of whole blood, approximately 2 X 10 6 PBMCs were obtained. Lymphocytes were separatedby densitygradient centrifugation overficoll-sodium diatrizoate (specific gravity 1.077;Sigma,St. Louis, MO) and washed twice with phosphate buffered saline (PBS) without Ca 2 + or Mg2+. CD2 (T-cell surface marker) and CD19 (B-cellsurfacemarker)positivecells were preparedusing appropriate antibody coated magnetic beads (Dynal, Lake Success,NY) accordingto the procedureprovidedby Dynal.To checkfor purityof the separation CD19-positive cellspriorto extraction,cells were detachedfrom the beads by using Detach-aBead (Dynal). The purityof CD2-positive cells was evaluated followingtrypsin-EDTA (GmCOIBRL, Gaithersburg, MD) for 15 min, a PBS wash, and overnight culture at 37°C in RPMI 1640 supplemented with500 D/mlpenicillin G, 500 g/ml streptomycin, 1.5 mM L-glutamine, 25 mM HEPES (15) . Immunostaining, usingmonoclonalantibodies (Coulter, Hialeah,FL), and flowcytometrywere then performedas previously described (12) .All BandT-cell preparations wereat least95% pure.
RNA extraction and reverse transcription.-Total RNA obtained from human T and B cells was isolated using the singlestep isolationmethod (16) .The reversetranscriptionfrom RNA to cDNA was performed as previously described using equal amountsof RNA from B or T cells (8) . Briefly, a total volumeof 25J.1l contains 3Jigtotal RNA, 1J.1l random primer (90 units/mI), IX first strand buffer (250 mM Tris HCl, 375 mM KCl, 15 mM Oligonucleototides.--GH primers flanking exons 2, 3, and 4 in human GH gene were synthesized as mentioned previously (8) . The sense primer (5' end) is located within the last 20 nucleotides of exon 2 and the first 7 nucleotides of exon 3 of the human GH gene. The antisense primer (3' end) is complementary to the last 6 and the first 21 nucleotides of exons 3 and 4 so that contamination by genomic DNA would be avoided (8) . The amplified fragments were 161bp in length. The sequence of sense primer was 5'-ATGACA CCT ATC AGG AGT TTG AAG AAG-3', of the antisense primer was 5'-GAT GCG GAG CAG CTC TAGGTI AGA TIT-3'.
Competitive RT-PCR.-A competitive RT-PCR method for GH was described in our previous study (13) . Briefly,a rat p53 gene fragment(241bp) was chosenfor use as a competitive standard that differed in size from target gene-GH (161bp) PCR product. This competitive standardconsistsof a nonhomologous DNA fragment with primer templatesthat "mimic" and are thus recognizedby GH gene-specific primers.The competitivestandard 1:2 dilution series began at 0.312x10-4 attomoles and proceeded to 10x10-4 attomoles.PCR products were generatedin a volume of 12.5Ji1, containing 2 J.1l of the serial diluted competitivestandard, 1.5 J.1l of cDNA (equivalent to about0.25 Jig of total RNA), 10 mM Tris-HCl (pH 8.3), 50 mM KC12.5 mM MgC12, 25 pmol of each primer, 0.2 mM of each dA~dGTP, dcrn and dTTP (GffiCOIBRL), and 0.6 J.1l of Taq-Start mix. The Taq-Start mix containing80J.1l Taq DNA polymerase (GffiCOIBRL), 80 J.1l Taq antibody and 320 J.1l dilution buffer (Clontech, Palo Alto, CA) was utilizedto minimize PCR amplification of nonspecific fragments. Amplification was carriedout in an automatedPerkinElmer/Cetus 9600 thermal cycler for initial denaturation for 1 min at 94°C, then for 35 cycles of denaturation for 30 sec at 94°C, annealing for 30 sec at 62°C and extension for 30 sec at 72°C, followed by a terminalincubation for 7 min at 72°C.
The productsfrom each reaction were examined on ethidium bromide-stained 3% agarose gel. A typical photograph of a competitive standard dilution series with one human PBMC RNA sample is shown in Figure 1 . The intensities of target and mimic fragments were determined using a digital IS-1000 imaging system(AlphaInnotech, San Leandro,CA).
Two independent competitive RT-PCR studies were performed for each sample,and each independentexperimentgave similar results. These data were analyzed using the nonparametric Wilcoxon-Kruskal-Wallis test, and a p < .05 was considered significant.
RESULTS

Separation of PBMCs into T-and B-cell populations.-
PBMCs from subjects were separated into CD2 (T cell) and CD 19 (B cell) by using the appropriate magnetic bead-coated antibodies. The purity of the separated cells was tested by immunostaining and flow cytometry. Both T-and B-cell populations were greaterthan 95% pure (data not shown).
Competitive PCR ofGH mRNA.-To determine appropriate dilutions of competitive standard for competitive PCR, we did preliminary titrationexperiments in which 10 twofold serial dilutions (from 0.78 X 10-5 to 40 X 10-4) were empirically made and coamplifiedwith a constant amount of sampleeDNA. After acquiring this information, we were able to reduce the number of serial dilutions to six (0.312 X 10-4 to 10 X 10-4), which allowed both competitive standard and target GH fragments to be amplifiedand visualizedon an agarose/EtBrgel.
To compare GH cDNA levels in T-cell and B-cell populations from the two experimental groups, we performed PCR amplificationof four samples at the same time. One fifth of the amplified product from these four samples was then examined on a single agarose/EtBrgel.A typical photographof a competitive standard dilution series with one of the human PBMC RNA samplesis shownin Figure 1 .
The expression ofGH mRNA in T andB cells.-Chronic stressrelated changes in GH mRNA levelsin human T-celland B-cell populations were measured using a competitive RT-PCRtechnique. In thecontrolgroupwe foundthreefold greaterGH mRNA expression in B cells than in T cells (p < .05), even though the totalT-cellpopulation is 3-4 timesgreaterthan the B-cellpopulation in man (Figure 2) . We also noted that B-and T-cell GH mRNA levels were highly correlated (R = 0.5,p < .05). Further analysis showedthat the expression of GH mRNA from B cells was 60% less (p < .05)in the AD caregiver groupcomparedwith the controlwomen, whereasthe expression of GH mRNA fromT cellswas similar betweenthe two groups(p > .05).
DISCUSSION
In this study we combined two areas of investigation in which our laboratoryhas been active for severalyears. The first Figure 2 . Quantitative analysis of GH mRNA as measured by competitive RT-PCR aftercorrectingfor the difference in size betweenthe competitive standard fragment and eDNA. In the control (CT) group, B-cell GH mRNA was significantly (p < .05) higherthan T-cellGH mRNA. Also, caregivers(CG)had a 60% decrease in B-cell GH mRNA when compared to controls, whereasTcell GH MRNAconcentrations were similarbetweenthe two groups.When the 3 highest B-cell GH MRNA data points (2 in the controls and 1 in the caregivers)are eliminatedfrom the analysis, significant (p < .05)differences persist. the decreased GH mRNA reflecting a decrease in lymphocyte GH production, as the lower GH mRNA could also reflect increasedturnoverof mRNA and possiblyeven an increasein GH production.If we accepted the latter interpretation,however, it could be the first example of human stress increasing an immune peptide;thus, we believethe most parsimoniousinterpretationis that it is reflective of decreased GH production.
Recently, we have found that immune defects in caregivers include suppressionof lymphocyteGH levels.UtilizingquantitativePeR techniques,we observedthat caregivershave a50% decrease in lymphocyteGH mRNA (13) .In this study, we replicated these findings as we observed approximately a 50% decrease in the caregivers' GH mRNA compared to the age-and sex-matched controlwomen.Of markedinterestwas our finding that althoughGH mRNA levelsin T cells were similar between caregivers and control subjects, there was a marked 60% decrease in GH mRNA levels in Bcells in the caregiver population.This observationsuggeststhe possibilitythat a diminution in lymphocyte GH could be contributing to the defective antibody responseto repetitiveinfluenza vaccinethat we had previouslyreportedin the caregiver population (12) . Obviously, asso-
CT CG relates to the markedimmunologicdefects that characterizesocial isolation and chronic stress associated with caregiving of patients with AD (11, 14) ; the second concernsour observations that lymphocyte GH may be an important autocrine/paracrine factor in the human immune system (8, 13) . In our caregiver studies we have found decreased immune function-not only while they are active caregivers, but interestingly, even for years after bereavement for the AD patient when they are no longer caregiving (14) . Their cellular immune defects following chronic stress are characterizedby a decreasedproliferativeresponse to T-cellmitogens (17) and a decreasedresponse of NK cells to IFN--y and IL-2 (11).Also, there is an impairmentin the ability of these individuals to synthesize antibody to an influenzavirus vaccineand an impairmentin the virus-specific Tcell response (12) . We found that fewer than 50% of AD caregivers developed a fourfold antibody response after influenza virus vaccination, whichis considered the minimaleffective response to preventinfection.
B-cell T-cell
Meanwhile, we havebeen investigating lymphocyte GH production and, along with others (6, (8) (9) (10) , noted that it can be produced and secretedby PBMCs and that antibodies or an antisense oligodeoxynucleotide to GH mRNA in serum-free medium can decrease mitogen-stimulatedlymphocytereplication (6, 7) . Using in situ hybridization, we have noted GH mRNA in human thymus, tonsil,spleen, and lymph nodes (8) .
We observed that there was almost three times as much GH in the B cells as in theT cells.One could arguethat 1%-5% contaminationof the DynabeadB-and T-cellpurifiedcell preparations could have influenced the PCR GH mRNA results. However, we feel that the consistencyand the magnitudeof the differencebetween the T-cell and B-cell group makes this argument less tenable.Also, one has to qualify the interpretation of dation does not prove causality, and this observation could be secondary to a B-and/or T-cell defect. There are, however, several reports that make this suggestion plausible. First, Yoshida and colleagues (2) have shown that GH, when incubated with lymphocytes in vitro, increased IgG production. Also, there is an intriguing observation made by Stephenson and coworkers (18) that OH, when administered in concert with a viral vaccine, was able to dramatically improve survival in animals challenged with this encephalitic virus. Although we have not yet seen differences in serum GH levels between controls and caregivers, it is important to remember that lymphocyte GH has little if any influence on serum GH levels. The secretion of lymphocyte GH is several orders of magnitude lower than that secreted by the pituitary gland, and it usually is not measurable even by the most sensitive chemiluminescence assays (9, 10) . OH has been visualized by in situ hybridization in several immune organs (8) , and it appears that lymphocyte GH produces its immune effects by an autocrine or paracrine mechanism.
In summary, we have demonstrated that the B cell is more active than the T cell in lymphocyte GH mRNA synthesis. Also, the decrease in levels in lymphocyte GH mRNA that occurs in chronically stressed AD caregivers occurs predominantly in B cells. These data add to the growing body of information dealing with the endocrine-immune interface and suggest that pituitary hormones that are synthesized by the central and peripheral immune system may beactive participants in a wide variety of challenges to immune function.
